SAN FRANCISCO, October 10, 2017 /PRNewswire/ --

The global brachytherapy market is expected to reach USD 486.9 million by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to increasing geriatric population, unhealthy lifestyle, mergers & acquisitions, and unmet needs of cancer care in low- and middle-income countries.

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

Furthermore, there is rising competition in the brachytherapy market due to technological advancements and presence of players, such as C.R. Bard, Inc.; Elekta AB (pub); IsoRay, Inc.; and Argon Medical Devices, Inc. Hence, brachytherapy market is expected to witness lucrative growth during the forecast period.

According to American Brachytherapy Society, safety and efficacy of brachytherapy treatment over other cancer treatments, such as chemotherapy and surgery, is expected to boost the market.

Browse full research report with TOC on "Brachytherapy Market Analysis By Type (High Dose Rate Brachytherapy, Low Dose Rate Brachytherapy), By Application (Prostate, Gynecological, Breast), By Region And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market

Further Key Findings From the Report Suggest: 

• In 2016, High-Dose Rate (HDR) brachytherapy dominated the market. Furthermore, the HDR brachytherapy segment is anticipated to grow at the fastest CAGR owing to factors such as growing incidence of breast cancer, unhealthy lifestyle, increase in research initiatives, and introduction of technological advancements by key players
• HDR brachytherapy decreases radiation exposure time as its implantation is temporary, making it more convenient for patients than LDR brachytherapy in which radiation sources are permanently implanted
• The application segment comprises of prostate cancer, breast cancer, and gynecological cancer. The breast cancer segment is expected to exhibit lucrative growth by 2025 with a CAGR of more than 5%, as breast cancer is the second most common cancer according to GLOBOCAN
• Geographic expansion into Europe, Asia Pacific, and Middle East & Africa by well-established players is anticipated to promote fastest growth in the region
• Asia Pacific is the fastest growing region due to increased prevalence of cancer and increasing access to radiation therapy, such as Esteya, an electronic brachytherapy system for treating skin cancer
• Some of the key players in the brachytherapy market are Elekta AB (pub); Varian Medical Systems, Inc.; IsoRay Medical, Inc.; iCAD, Inc.; and Eckert & Ziegler BEBIG
• In August 2016, Eckert & Ziegler BEBIG acquired BrachySolutions BVBA, one of the largest European prostate seed distributors, for portfolio enhancement. Through this acquisition, the company has secured a strong position in Europe as a seed manufacturer.

Browse related reports by Grand View Research: 

• Benchtop Automation Market - http://www.grandviewresearch.com/industry-analysis/benchtop-automation
• Nucleic Acid Isolation and Purification Market - http://www.grandviewresearch.com/industry-analysis/nucleic-acid-solation-and-purification-market
• Ambulance Services Market - http://www.grandviewresearch.com/industry-analysis/ambulance-services-market
• Artificial Limbs and Joints Market - http://www.grandviewresearch.com/industry-analysis/artificial-limbs-and-joints-market

Grand View Research has segmented the global brachytherapy market on the basis of type, application, and region: 

• Type (Revenue, USD Million, 2014 - 2025)
  • High Dose Rate (HDR) Brachytherapy
  • Low Dose Rate (LDR) Brachytherapy
• Application (Revenue, USD Million, 2014 - 2025)
  • Prostate cancer
  • Gynecological cancer
  • Breast cancer
  • Others
• Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East Asia
    • South Africa

Read Our Blog By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com

SOURCE Grand View Research, Inc.